Comment on: Benchmarking tocilizumab use for giant cell arteritis
Rheumatol Adv Pract
.
2022 Aug 23;6(3):rkac069.
doi: 10.1093/rap/rkac069.
eCollection 2022.
Authors
Shalini Janagan
1
,
Catherine Guly
2
,
Sarah Skeoch
3
,
Joanna C Robson
1
4
Affiliations
1
Department of Rheumatology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
2
Bristol Eye Hospital, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
3
Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK.
4
Rheumatology Research, Faculty of Health and Applied Science, University of the West of England, Bristol, UK.
PMID:
36133959
PMCID:
PMC9479882
DOI:
10.1093/rap/rkac069
No abstract available